Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Cortinovis

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Central European Journal of Public Health|January 25, 2007
Socio-demographic status and alcohol drinking patterns among Greek healthy adultsPandelis Pazarlis, Davide Mauri, Ivan Cortinovis, et al.
Hematological Oncology|July 31, 2019
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approachAlessandra Iurlo, Elena Maria Elli, Francesca Palandri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2013
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Anna Bossi, Ivan Cortinovis, et al.
Hematological Oncology|September 26, 2020
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter seriesAlessandra Iurlo, Francesca Palandri, Elena Maria Elli, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 22, 2009
Screening practice and misplaced prioritiesDavide Mauri, Antonis Valachis, Nikolaos P Polyzos, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Central European Journal of Public Health|January 25, 2007
Socio-demographic status and alcohol drinking patterns among Greek healthy adultsPandelis Pazarlis, Davide Mauri, Ivan Cortinovis, et al.
Hematological Oncology|July 31, 2019
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approachAlessandra Iurlo, Elena Maria Elli, Francesca Palandri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2013
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Anna Bossi, Ivan Cortinovis, et al.
Hematological Oncology|September 26, 2020
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter seriesAlessandra Iurlo, Francesca Palandri, Elena Maria Elli, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 22, 2009
Screening practice and misplaced prioritiesDavide Mauri, Antonis Valachis, Nikolaos P Polyzos, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 5